Contact Information

9 Squares Building, Monalisha Township
Near Zanzarda Chowkdi, Junagadh 362001 (Gujrat, India)

(+ 91) 8866197888

(+ 91) 8866196888

health@worldprimeexport.com

Structure

MYCOPHENOLATE SODIUM

Product Description

Mycophenolate sodium (Myfortic® of Novartis) is an immunosuppressant drug used to prevent rejection in organ transplantation. It inhibits an enzyme needed for the growth of T cells and B cells. Mycophenolate sodium is indicated for the prevention of renal transplant rejection in adults. Mycophenolate sodium has also been used for the prevention of rejection in liver, heart, and/or lung transplants in children older than two years.An immunosuppressant that has drastically decreased the incidence of acute rejection in solid transplant recipients, Mycophenolate sodium is increasingly utilized as a steroid sparing treatment in immune-mediated disorders including immunoglobulin-A nephropathy, small vessel vasculitides, and psoriasis.

Details
Chemical Name MYCOPHENOLATE SODIUM
IUPAC Name sodium (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
CAS Number 37415-62-6
Molecular Formula C17H19NaO6
Synonyms sodiummycophenolate;MYCOPHENOLATE SODIUM;mycophenolicmonosodiumsalt;mycophenolicacidmonosodiumsalt;4-Hexenoic acid,6-(1,3-dihydro-4-hydroxy-6-Methoxy-7-Methyl-3-oxo-5-isobenzofuranyl)-4-Methyl-,sodiuM salt
Application Immunosuppressant